Phreesia Q1 revenue $83.8M (+32% YoY); net loss narrows, FY24 EBITDA outlook raised

Phreesia, Inc.

2024-Q1 EPS reported -$0.70 revenue$83,845,000

Total revenue $83.8M, up 32% YoY; net loss $37.5M vs $51.2M in prior-year quarter.
Adjusted EBITDA -$13.8M (improved from -$30.6M); FY24 outlook raised to -$60M to -$55M.
AHSCs 3,309 (+31% YoY); Network Solutions revenue +46% driven by Life Sciences campaigns.
SVB consent extended to Sep 15, 2023; cash reserves $149.8M sufficient for 12+ months.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Phreesia, Inc. reported fiscal first quarter ended April 30, 2023 results: revenue $83.8 million, net income $37.5 million. Guidance raised.

Period: fiscal first quarter ended April 30, 2023
Revenue: $83.8 million
Net income: $37.5 million
Guidance: raised
Result: reported results

Exact text from the filing

relations website at ir.phreesia.com to view the Company's Q1 Fiscal Year 2024 Stakeholder Letter. Fiscal First Quarter Ended April 30, 2023 Highlights • Total revenue was $83.8 million in the quarter as compared to $63.4 million in the same period in the prior year, an increase of 32%. • Average number of healthcare services clients ("AHSCs") was 3,309 in the

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

Phreesia, Inc. filing history →

Source: SEC EDGAR

accession 0001412408-23-000073

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.